Signaling of type II oncostatin M receptor.

The Journal of Biological Chemistry
P AugusteH Gascan

Abstract

Oncostatin M (OSM) mediates its bioactivities through two different heterodimer receptors. They both involve the gp130-transducing receptor, which dimerizes with either leukemia inhibitory receptor beta or with OSM receptor beta (OSMRbeta) to generate, respectively, type I and type II OSM receptors. Co-precipitation of gp130-associated proteins, flow cytometry, polymerase chain reaction, and tyrosine phosphorylation analyses allowed the characterization of both types of OSM receptors expressed on the surface of different cell lines. It also allowed the detection of a large size protein, p250, that specifically associates to the type II OSM receptor components and that is tyrosine-phosphorylated after the activation peak of the gp130.OSMRbeta heterocomplex. The restricted expression of type I OSM receptor by the JAR choriocarcinoma cell line, and type II receptor by the A375 melanoma cell line, permitted the characterization of their signaling machineries. Both type I and type II OSM receptors activated Jak1, Jak2, and Tyk2 receptor-associated tyrosine kinases. The information is next relayed to the nucleus by the STAT3 transcriptional activator, which is recruited by both types of OSM receptors. In addition, STAT5b was specific...Continue Reading

References

Jan 1, 1992·Progress in Growth Factor Research·A G BruceT M Rose
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·T M Rose, A G Bruce
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J M ZarlingG J Todaro
Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·T G BoultonG D Yancopoulos
May 17, 1996·The Journal of Biological Chemistry·M FourcinH Gascan
Feb 21, 1997·The Journal of Biological Chemistry·O RobledoH Gascan

❮ Previous
Next ❯

Citations

Dec 1, 1999·Life Sciences·M J Gómez-Lechón
Aug 27, 1999·Molecular Medicine Today·S L Grant, C G Begley
Apr 1, 2000·Cytokine & Growth Factor Reviews·P M GrimleyH Rui
Feb 8, 2011·Assay and Drug Development Technologies·Natalie FursovGordon Powers
Nov 13, 2007·Reproductive Biology and Endocrinology : RB&E·Katja J TeerdsEddy Rijntjes
Sep 24, 1999·Biological Chemistry·J GrötzingerS Rose-John
Jan 2, 2014·ISRN Inflammation·Carl D Richards
Sep 25, 2015·Journal of Cellular Biochemistry·Sucharita SahaSumita Sengupta Bandyopadhyay
Aug 19, 2006·The Journal of Investigative Dermatology·Alix GazelMiroslav Blumenberg
Sep 1, 2009·Trends in Genetics : TIG·Gavin C Conant
Aug 13, 2003·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·K A O'HaraD A Knight
Jul 23, 2015·Cytokine & Growth Factor Reviews·Heike M Hermanns
Jan 9, 2013·The Biochemical Journal·Antje SchüttDirk Schmidt-Arras
Mar 8, 2018·The Journal of Biological Chemistry·Juan M Adrian-SegarraJochen Pöling
Jun 22, 2018·Scandinavian Journal of Immunology·Nathaniel R WestAhmed N Hegazy
Nov 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y ItoA Miyajima
Nov 18, 2008·Melanoma Research·Jessica C HasselClaudia Wellbrock
Dec 20, 2007·Expert Review of Molecular Diagnostics·Rowena S Lewis, Alister C Ward
Apr 24, 2008·The Journal of Biological Chemistry·Christoph HintzenHeike M Hermanns
Aug 8, 2015·American Journal of Physiology. Gastrointestinal and Liver Physiology·Muhammad Imran ArshadMichel Samson
Nov 7, 2019·Cancers·Kelsey L PolakMark W Jackson
Feb 22, 2000·The Journal of Biological Chemistry·C OlivierH Gascan
Jan 12, 2002·The Journal of Biological Chemistry·Simone RadtkeIris Behrmann
Jun 20, 2000·The Journal of Biological Chemistry·F BlanchardH Baumann

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.